Can next week's Apple, Palantir and AMD results steady a shaken market?

Investors hoping for earnings to lift equities had a rough stretch this week. Several high-profile releases triggered steep selloffs, showing how fast buying pressure can reverse when numbers or guidance fall short.

Intel illustrated the point. Adjusted earnings came in at $0.52 a share, above the $0.41 consensus, while revenue of $16.50 billion missed the $16.60 billion projection. That profit surprise did not help much: the stock was off roughly 25.7% during Friday morning trading.

Amazon felt similar heat, with shares down about 6.3% in after-hours trading Thursday before recovering. The company’s results drew renewed attention to the trade-off among growth, capital spending and remaining shareholder cash flow.

That makes the coming week more consequential. Topping the headline profit number can catch investors’ eyes, but guidance, margins and planned outlays will decide if that interest turns into purchases.

Apple and Palantir lead the Monday post-market reports, with AMD, Super Micro Computer and Arista Networks due Tuesday. Wednesday’s tech slate gains Uber, Qualcomm, Arm and AppLovin.

The key issue hanging over the AI trade is unchanged: can robust demand validate the heavy spending and feed through to better earnings and cash flow?

Monday: Apple and Palantir lead the way.

Reporting before Monday’s opening bell are Check Point Software, Estée Lauder, Marriott International and Tower Semiconductor.

Scheduled after the close are Apple, Palantir and Roku.

Apple’s report centers on iPhone demand, growth in services, how the company did in China and its outlook for the holiday quarter. Investors are also watching for signs that AI capabilities are giving consumers a strong incentive to buy new hardware.

Palantir is up against a different challenge: can commercial and government demand keep its rapid growth going without hurting margins? The outlook it provides will count heavily in deciding whether the numbers pull in fresh buyers.

Roku adds a fresh look at advertising appetite and how people are streaming.

Tuesday: AI infrastructure comes under serious scrutiny.

Tuesday’s pre-open reports come from Shopify, Pfizer, Marathon Petroleum, Eaton and Apollo Global Management.

Due after Tuesday’s close are AMD, Super Micro Computer, Arista Networks, Astera Labs, Booking Holdings and Amgen.

Tuesday’s calendar provides a wide-ranging look at the AI infrastructure supply chain. AMD’s data-center results and outlook for AI accelerators should serve as important gauges of chip demand.

With Super Micro Computer, the focus goes past server revenue to margins, working-capital requirements and cash production. Heavy demand is welcome, yet investors also need convincing that shipping those systems brings good returns.

Arista Networks and Astera Labs should shed light on spending for networking and connectivity. Eaton contributes more context via electrical gear and the electricity needs of growing data centers.

Away from AI, Shopify gives a view of merchant activity and e-commerce spending, and Booking Holdings updates the reading on travel demand.

Wednesday swings the spotlight to chips, software and consumer behavior.

Reporting before Wednesday’s bell are Uber, Novo Nordisk, Datadog, GlobalFoundries, McDonald’s and CVS Health.

Wednesday’s post-close lineup includes AppLovin, Qualcomm, Arm, Coherent, Cava and Dutch Bros.

Uber’s bookings, profitability and outlook should give a glimpse of demand for rides and deliveries. McDonald’s, Cava and Dutch Bros should reveal where consumer dollars are going, and the degree to which discounts, prices and operating expenses are squeezing margins.

Qualcomm and Arm move the focus to smartphone demand, licensing patterns and non-handset opportunities. Coherent supplies another data point on demand for optical communications.

Datadog’s numbers are expected to clarify cloud activity and corporate spending. AppLovin’s ad growth, profitability and guidance make it another key read on sentiment in tech.

Novo Nordisk turns attention to weight-loss and diabetes drugs, covering sales growth, rivals and pricing. CVS Health contributes a look at healthcare expenses and how its operations are performing.

Thursday centers on optical demand, cloud outlays and travel.

Thursday’s morning reports feature Unity, Cardinal Health, Celsius, Core Scientific and Cigna.

After Thursday’s close come Lumentum, Applied Optoelectronics, Cloudflare and Airbnb.

Lumentum and Applied Optoelectronics continue the review of optical connectivity and data-center spending. The key is whether demand is showing up in higher sales, better margins and a positive outlook.

Cloudflare offers another gauge of business technology budgets and whether customer interest can be turned into profitable expansion.

Airbnb’s bookings and outlook add to the travel-demand picture, and Cigna’s results keep the spotlight on healthcare use and medical expenses.

Friday wraps the week with healthcare and consumer spending.

Reporting Friday morning are Moderna, Humana and Under Armour.

Humana’s medical-cost patterns and outlook will get close attention for any strain on profits. Moderna’s release will highlight its commercial prospects, spending and drug-development pipeline.

Under Armour adds another view of discretionary purchases, discounting and margin behavior. Investors want signs that its turnaround efforts are starting to work.

The essential question is whether the numbers lure buyers back.

Recent sessions proved that merely topping earnings estimates does not ensure a share-price gain. What investors are seeking is conviction about the path ahead: lasting demand, disciplined costs, better cash flow and guidance that backs the consensus.

The week ahead should show whether recent weakness pulls in buyers or weak guidance hands sellers fresh ammunition.

Traders will keep watching how prices respond. Does a positive surprise lift shares and keep them higher? Can a stock take bad news in stride and protect key support? If a bounce stalls at resistance, sellers stay dominant. If prices climb back over damaged technical levels, buyers get a foundation.